{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:13:35Z","timestamp":1790018015351,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Toxoplasma gondii<\/jats:italic> is an intracellular protozoan parasite that can modulate the microenvironment of infected hosts and is known to be associated with the incidence of brain tumor growth. In this study, we suggested that the exosomal microRNA-21 derived from <jats:italic>Toxoplasma<\/jats:italic> infection would contribute to the growth of brain tumors. Exosomes of BV2 microglial cells infected with <jats:italic>Toxoplasma<\/jats:italic> were characterized and confirmed internalization to U87 glioma cells. Exosomal miRNA expression profiles were analyzed using microRNA array and miR-21A-5p associated with <jats:italic>Toxoplasma<\/jats:italic> and tumor sorted. We also examined the mRNA level of tumor-associated genes in U87 glioma cells by changing the level of miR-21 within exosomes and the effects of exosomes on the proliferation of human U87 glioma cells. Expression of miRNA-21 was increased and anti-tumorigenic genes (FoxO1, PTEN, and PDCD4) were decreased in exosomes within <jats:italic>T. gondii<\/jats:italic>-infected U87 glioma cells. <jats:italic>Toxoplasma<\/jats:italic>-infected BV2-derived exosomes induced proliferation of U87 glioma cells. The exosomes induced the growth of U87 cells in a mouse tumor model. We suggest that the increased exosomal miR-21 from <jats:italic>Toxoplasma<\/jats:italic>-infected BV2 microglial cells may play an important role as a cell growth promotor of U87 glioma cells through a down-regulation of anti-tumorigenic genes.<\/jats:p>","DOI":"10.1038\/s41598-022-20281-w","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T17:09:00Z","timestamp":1664557740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Exosomal miRNA-21 from Toxoplasma gondii-infected microglial cells induces the growth of U87 glioma cells by inhibiting tumor suppressor genes"],"prefix":"10.1038","volume":"12","author":[{"given":"Bong-Kwang","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyemi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyejoo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Yil","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"20281_CR1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay, J. et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer 144, 1941\u20131953 (2019).","journal-title":"Int. J. Cancer"},{"key":"20281_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112119","volume":"143","author":"S Rasheed","year":"2021","unstructured":"Rasheed, S., Rehman, K. & Akash, M. S. An insight into the risk factors of brain tumors and their therapeutic interventions. Biomed. Pharmacother. 143, 112119 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"20281_CR3","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201846632","volume":"19","author":"D van Elsland","year":"2018","unstructured":"van Elsland, D. & Neefjes, J. Bacterial infections and cancer. EMBO Rep. 19, e46632 (2018).","journal-title":"EMBO Rep."},{"key":"20281_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3390\/cancers14020425","volume":"14","author":"I Kato","year":"2022","unstructured":"Kato, I., Zhang, J. & Sun, J. Bacterial-viral interactions in human orodigestive and female genital tract cancers: A summary of epidemiologic and laboratory evidence. Cancers 14, 425 (2022).","journal-title":"Cancers"},{"key":"20281_CR5","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.210004","volume":"11","author":"KL Magon","year":"2021","unstructured":"Magon, K. L. & Parish, J. L. From infection to cancer: How DNA tumour viruses alter host cell central carbon and lipid metabolism. Open Biol. 11, 210004 (2021).","journal-title":"Open Biol."},{"key":"20281_CR6","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fgene.2014.00444","volume":"5","author":"JM Correia da Costa","year":"2014","unstructured":"Correia da Costa, J. M. et al. Schistosome and liver fluke derived catechol-estrogens and helminth associated cancers. Front. Genet. 5, 444 (2014).","journal-title":"Front. Genet."},{"key":"20281_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0188-4409(00)00049-7","volume":"31","author":"OH Del Brutto","year":"2000","unstructured":"Del Brutto, O. H. et al. Neurocysticercosis and oncogenesis. Arch. Med. Res. 31, 151\u2013155 (2000).","journal-title":"Arch. Med. Res."},{"key":"20281_CR8","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMoa1505892","volume":"373","author":"A Muehlenbachs","year":"2015","unstructured":"Muehlenbachs, A. et al. Malignant transformation of Hymenolepis nana in a human host. N. Engl. J. Med. 373, 1845\u20131852 (2015).","journal-title":"N. Engl. J. Med."},{"key":"20281_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104660","volume":"137","author":"J Xiao","year":"2022","unstructured":"Xiao, J., Savonenko, A. & Yolken, R. H. Strain-specific pre-existing immunity: A key to understanding the role of chronic Toxoplasma infection in cognition and Alzheimer\u2019s diseases?. Neurosci. Biobehav. Rev. 137, 104660 (2022).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"20281_CR10","volume-title":"Textbook of Pediatric Gastroenterology, Hepatology, and Nutrition","author":"P Hodges","year":"2020","unstructured":"Hodges, P. & Kelly, P. Intestinal parasites. In Textbook of Pediatric Gastroenterology, Hepatology, and Nutrition (eds Guandalini, S. & Dhawan, A.) (Springer, 2020)."},{"key":"20281_CR11","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1080\/21505594.2021.2012346","volume":"12","author":"SG Sanchez","year":"2021","unstructured":"Sanchez, S. G. & Besteiro, S. The pathogenicity and virulence of Toxoplasma gondii. Virulence 12, 3095\u20133114 (2021).","journal-title":"Virulence"},{"key":"20281_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2022.102119","volume":"77","author":"A Abdollahi","year":"2022","unstructured":"Abdollahi, A. et al. Toxoplasma gondii infection\/exposure and the risk of brain tumors: A systematic review and meta-analysis. Cancer Epidemiol. 77, 102119 (2022).","journal-title":"Cancer Epidemiol."},{"key":"20281_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ije\/22.3.412","volume":"22","author":"P Ryan","year":"1993","unstructured":"Ryan, P. et al. Tumours of the brain and presence of antibodies to Toxoplasma gondii. Int. J. Epidemiol. 22, 412\u2013419 (1993).","journal-title":"Int. J. Epidemiol."},{"key":"20281_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1098\/rsbl.2011.0588","volume":"8","author":"F Thomas","year":"2012","unstructured":"Thomas, F. et al. Incidence of adult brain cancers is higher in countries where the protozoan parasite Toxoplasma gondii is common. Biol. Lett. 8, 101\u2013103 (2012).","journal-title":"Biol. Lett."},{"key":"20281_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-9378-8-8","volume":"8","author":"S Thirugnanam","year":"2013","unstructured":"Thirugnanam, S., Rout, N. & Gnanasekar, M. Possible role of Toxoplasma gondii in brain cancer through modulation of host microRNAs. Infect. Agent. Cancer 8, 8 (2013).","journal-title":"Infect. Agent. Cancer"},{"key":"20281_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1042\/BST20120217","volume":"41","author":"P Deolindo","year":"2013","unstructured":"Deolindo, P., Evans-Osses, I. & Ramirez, M. I. Microvesicles and exosomes as vehicles between protozoan and host cell communication. Biochem. Soc. Trans. 41, 252\u2013257 (2013).","journal-title":"Biochem. Soc. Trans."},{"key":"20281_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.semcancer.2021.03.032","volume":"74","author":"A Yokoi","year":"2021","unstructured":"Yokoi, A. & Ochiya, T. Exosomes and extracellular vesicles: Rethinking the essential values in cancer biology. Semin. Cancer Biol. 74, 79\u201391 (2021).","journal-title":"Semin. Cancer Biol."},{"key":"20281_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3892\/ijo.2021.5224","volume":"59","author":"X Wang","year":"2021","unstructured":"Wang, X., Zhou, Y. & Ding, K. Roles of exosomes in cancer chemotherapy resistance, progression, metastasis and immunity, and their clinical applications (review). Int. J. Oncol. 59, 44 (2021).","journal-title":"Int. J. Oncol."},{"key":"20281_CR19","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ygyno.2021.02.004","volume":"161","author":"M Hashemipour","year":"2021","unstructured":"Hashemipour, M. et al. Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers. Gynecol. Oncol. 161, 314\u2013327 (2021).","journal-title":"Gynecol. Oncol."},{"key":"20281_CR20","first-page":"2","volume":"11","author":"SM Pope","year":"2013","unstructured":"Pope, S. M. & Lasser, C. Toxoplasma gondii infection of fibroblasts causes the production of exosome-like vesicles containing a unique array of mRNA and miRNA transcripts compared to serum starvation. J. Extracell. Vesicles 11, 2 (2013).","journal-title":"J. Extracell. Vesicles"},{"key":"20281_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.abb.2015.07.001","volume":"15","author":"G Wang","year":"2015","unstructured":"Wang, G. et al. Targeting strategies on miRNA-21 and PDCD4 for glioblastoma. Arch. Biochem. Biophys. 15, 64\u201374 (2015).","journal-title":"Arch. Biochem. Biophys."},{"key":"20281_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/labinvest.2009.126","volume":"90","author":"X Zhou","year":"2010","unstructured":"Zhou, X. et al. Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab. Investig. 90, 144\u2013155 (2010).","journal-title":"Lab. Investig."},{"key":"20281_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ijpara.2020.11.010","volume":"51","author":"MM Maia","year":"2021","unstructured":"Maia, M. M. et al. Immunization with extracellular vesicles excreted by Toxoplasma gondii confers protection in murine infection, activating cellular and humoral responses. Int. J. Parasitol. 51, 559\u2013569 (2021).","journal-title":"Int. J. Parasitol."},{"key":"20281_CR24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1631\/jzus.B2100877","volume":"23","author":"K Du","year":"2022","unstructured":"Du, K. et al. Toxoplasma gondii infection induces cell apoptosis via multiple pathways revealed by transcriptome analysis. J. Zhejiang Univ. Sci. B 23, 315\u2013327 (2022).","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"20281_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.pt.2021.12.004","volume":"38","author":"MN Cowan","year":"2022","unstructured":"Cowan, M. N., Sethi, I. & Harris, T. H. Microglia in CNS infections: Insights from Toxoplasma gondii and other pathogens. Trends Parasitol. 38, 217\u2013229 (2022).","journal-title":"Trends Parasitol."},{"key":"20281_CR26","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.coi.2007.05.007","volume":"19","author":"G Raes","year":"2007","unstructured":"Raes, G. et al. Alternatively activated macrophages in protozoan infections. Curr. Opin. Immunol. 19, 454\u2013459 (2007).","journal-title":"Curr. Opin. Immunol."},{"key":"20281_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0065-230X(08)60278-X","volume":"53","author":"CA Facer","year":"1989","unstructured":"Facer, C. A. & Playfair, J. H. Malaria, Epstein\u2013Barr virus, and the genesis of lymphomas. Adv. Cancer Res. 53, 33\u201372 (1989).","journal-title":"Adv. Cancer Res."},{"key":"20281_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004289","volume":"10","author":"O Twu","year":"2014","unstructured":"Twu, O. & Johnson, P. J. Parasite extracellular vesicles: Mediators of intercellular communication. PLoS Pathog. 10, e1004289 (2014).","journal-title":"PLoS Pathog."},{"key":"20281_CR29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/1756-3305-6-356","volume":"16","author":"Y Cai","year":"2013","unstructured":"Cai, Y. et al. STAT3-dependent transactivation of miRNA genes following Toxoplasma gondii infection in macrophage. Parasit. Vectors 16, 356 (2013).","journal-title":"Parasit. Vectors"},{"key":"20281_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008742","volume":"5","author":"GM Zeiner","year":"2010","unstructured":"Zeiner, G. M. et al. Toxoplasma gondii infection specifically increases the levels of key host microRNAs. PLoS\u00a0One 5, e8742 (2010).","journal-title":"PLoS\u00a0One"},{"key":"20281_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11060-013-1155-x","volume":"114","author":"SK Hermansen","year":"2013","unstructured":"Hermansen, S. K. & Kristensen, B. W. MicroRNA biomarkers in glioblastoma. J. Neurooncol. 114, 13\u201323 (2013).","journal-title":"J. Neurooncol."},{"key":"20281_CR32","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1007\/s11010-021-04053-0","volume":"476","author":"Y Yu","year":"2021","unstructured":"Yu, Y. et al. The role of exosomal microRNAs in central nervous system diseases. Mol. Cell Biochem. 476, 2111\u20132124 (2021).","journal-title":"Mol. Cell Biochem."},{"key":"20281_CR33","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"103","author":"S Volinia","year":"2006","unstructured":"Volinia, S. et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U.S.A. 103, 2257\u20132261 (2006).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"20281_CR34","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1042\/BST0370918","volume":"37","author":"SD Selcuklu","year":"2009","unstructured":"Selcuklu, S. D., Donoghue, M. T. & Spillane, C. miR-21 as a key regulator of oncogenic processes. Biochem. Soc. Trans. 37, 918\u2013925 (2009).","journal-title":"Biochem. Soc. Trans."},{"key":"20281_CR35","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.celrep.2014.05.007","volume":"7","author":"Y Chen","year":"2014","unstructured":"Chen, Y. et al. Dysregulation of the miR-324-5p-CUEDC2 axis leads to macrophage dysfunction and is associated with colon cancer. Cell Rep. 7, 1982\u20131993 (2014).","journal-title":"Cell Rep."},{"key":"20281_CR36","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11060-009-9843-2","volume":"92","author":"S Lawler","year":"2009","unstructured":"Lawler, S. & Chiocca, E. A. Emerging functions of microRNAs in glioblastoma. J. Neurooncol. 92, 297\u2013306 (2009).","journal-title":"J. Neurooncol."},{"key":"20281_CR37","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1038\/onc.2008.72","volume":"27","author":"Z Lu","year":"2008","unstructured":"Lu, Z. et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27, 4373\u20134379 (2008).","journal-title":"Oncogene"},{"key":"20281_CR38","doi-asserted-by":"publisher","first-page":"14328","DOI":"10.1074\/jbc.M611393200","volume":"282","author":"S Zhu","year":"2007","unstructured":"Zhu, S., Si, M. L., Wu, H. & Mo, Y. Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem. 282, 14328\u201314336 (2007).","journal-title":"J. Biol. Chem."},{"key":"20281_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.onc.1210626","volume":"27","author":"T Goto","year":"2008","unstructured":"Goto, T. et al. Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells. Oncogene 27, 9\u201319 (2008).","journal-title":"Oncogene"},{"key":"20281_CR40","doi-asserted-by":"publisher","first-page":"15035","DOI":"10.18632\/oncotarget.3729","volume":"6","author":"H Go","year":"2015","unstructured":"Go, H. et al. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K\/AKT pathway in diffuse large B-cell lymphoma. Oncotarget 6, 15035\u201315049 (2015).","journal-title":"Oncotarget"},{"key":"20281_CR41","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1038\/onc.2008.25","volume":"27","author":"DN Gross","year":"2008","unstructured":"Gross, D. N., van den Heuvel, A. P. & Birnbaum, M. J. The role of FoxO in the regulation of metabolism. Oncogene 27, 2320\u20132336 (2008).","journal-title":"Oncogene"},{"key":"20281_CR42","doi-asserted-by":"publisher","first-page":"13613","DOI":"10.1073\/pnas.0405454101","volume":"101","author":"M Aoki","year":"2004","unstructured":"Aoki, M., Jiang, H. & Vogt, P. K. Proteasomal degradation of the FoXO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins. Proc. Natl. Acad. Sci. U.S.A. 101, 13613\u201313617 (2004).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"20281_CR43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3347\/kjp.2012.50.4.287","volume":"50","author":"H Lim","year":"2012","unstructured":"Lim, H. et al. Serologic survey of toxoplasmosis in Seoul and Jeju-do, and a brief review of its seroprevalence in Korea. Korean J. Parasitol. 50, 287\u2013293 (2012).","journal-title":"Korean J. Parasitol."},{"key":"20281_CR44","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fimmu.2018.00158","volume":"9","author":"YS Hwang","year":"2018","unstructured":"Hwang, Y. S. et al. Characteristics of infection immunity regulated by Toxoplasma gondii to maintain chronic infection in the brain. Front. Immunol. 9, 158 (2018).","journal-title":"Front. Immunol."},{"key":"20281_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138618","volume":"10","author":"J Perez-Hernandez","year":"2015","unstructured":"Perez-Hernandez, J. et al. Increased urinary exosomal microRNAs in patients with systemic lupus erythematosus. PLoS\u00a0One 10, e0138618 (2015).","journal-title":"PLoS\u00a0One"},{"key":"20281_CR46","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1111\/jcmm.14207","volume":"23","author":"SG Kim","year":"2019","unstructured":"Kim, S. G. et al. Increase in the nuclear localization of PTEN by the Toxoplasma GRA16 protein and subsequent induction of p53-dependent apoptosis and anticancer effect. J. Cell. Mol. Med. 23, 3234\u20133245 (2019).","journal-title":"J. Cell. Mol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20281-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20281-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20281-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T18:05:18Z","timestamp":1664561118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20281-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["20281"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-20281-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"assertion":[{"value":"9 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16450"}}